Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Assets: 2022-2025

Historic Other Non-Current Assets for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to $317,000.

  • Day One Biopharmaceuticals' Other Non-Current Assets rose 170.94% to $317,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $317,000, marking a year-over-year increase of 170.94%. This contributed to the annual value of $121,000 for FY2024, which is 43.46% down from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Other Non-Current Assets of $317,000 as of Q3 2025, which was up 73.22% from $183,000 recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Other Non-Current Assets registered a high of $487,000 during Q1 2023, and its lowest value of $117,000 during Q2 2024.
  • Over the past 3 years, Day One Biopharmaceuticals' median Other Non-Current Assets value was $214,000 (recorded in 2023), while the average stood at $220,909.
  • As far as peak fluctuations go, Day One Biopharmaceuticals' Other Non-Current Assets spiked by 195.15% in 2023, and later plummeted by 65.71% in 2024.
  • Quarterly analysis of 4 years shows Day One Biopharmaceuticals' Other Non-Current Assets stood at $469,000 in 2022, then tumbled by 54.37% to $214,000 in 2023, then tumbled by 43.46% to $121,000 in 2024, then surged by 170.94% to $317,000 in 2025.
  • Its Other Non-Current Assets stands at $317,000 for Q3 2025, versus $183,000 for Q2 2025 and $215,000 for Q1 2025.